Tweet
Upgraded Illumina HiSeq Chemistry
I recently heard a rumor that Illumina is about to introduce a new chemistry that will allow for 2x300bp output. I can't seem to find any more information about it and was wondering if any one else had heard the same thing. I am very interested in learning more about this and would like any information on the topic.
-
-
They have been sitting at 100bp reads for a long time. I would not expect a jump to 300 any time soon. You might have heard about 2x150, or 300 cycle hi seq chemistry.
300bp reads would most likely be on the Miseq first due to the small cycle time. -
They've recently mentioned 2x300bp for the MiSeq in the 2nd half of 2013.Comment
-
MiSeq
With the upgrade they are selling 500 cycle kits to run a 2x250 base run (with index). Haven't run it yet because we are using up our stock of v1 kits first.Comment
-
-
MiSeq not HiSeq
This is for the MiSeq right now-not the HiSeq. I don't think the HiSeq 2500 is going beyond 2 x 150Originally posted by snetmcom View PostComment
-
this thread is about hiseq. which is why i found your note confusing.Originally posted by kwaraska View PostComment
-
FWIW, at the recent Boston Illumina Users' Group Meeting in October, my memory is that 2x150 in rapid mode on the 2500 is the only longer chemistry on HiSeq that was discussed; when queried about 2x150 in standard mode or longer than 2x150 in rapid mode, the Illumina reps were not encouraging speculation that anything like that would be available soon.Comment
-
Data variability is still an issue in sequencing technologies despite the advances in reproducibility and accuracy of these platforms. But the problem does not originate in the sequencing itself, but in the previous steps, before the sample reaches the sequencer.
The first step is collection, followed by preservation and sample preparation for analysis. Most scientists overlook those steps, but not being careful might just be skewing the experiment’s results.
...06-02-2026, 10:05 AM -
With the launch of new single-cell sequencing platforms in 2026, the field stands at an exciting inflection point. This article surveys the most impactful advances in the field and discusses how they’re reshaping research in cancer, immunology, and beyond.
Introduction
Single-cell sequencing technologies have undergone remarkable advances over the past decade, transitioning from low-throughput experimental approaches to highly scalable platforms capable of...05-22-2026, 06:42 AM
Comment